Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Macrogenics (MGNX)

Macrogenics (MGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference GlobeNewswire - Tue Nov 25, 3:05PM CST

ROCKVILLE, MD, Nov. 25, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer,...

MGNX : 1.4000 (-0.71%)
MacroGenics: Q3 Earnings Snapshot AP - Wed Nov 12, 3:07PM CST

MacroGenics: Q3 Earnings Snapshot

MGNX : 1.4000 (-0.71%)
MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress GlobeNewswire - Wed Nov 12, 3:01PM CST

Achieved additional $75 million in partnering proceeds from Sanofi and Gilead Granted license to additional preclinical program to Gilead that leverages MacroGenics’ novel T-cell engager platform...

MGNX : 1.4000 (-0.71%)
MacroGenics to Participate in the Stifel 2025 Healthcare Conference GlobeNewswire - Thu Nov 6, 3:30PM CST

ROCKVILLE, MD, Nov. 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer,...

MGNX : 1.4000 (-0.71%)
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference GlobeNewswire - Tue Sep 2, 3:30PM CDT

ROCKVILLE, MD, Sept. 02, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer,...

MGNX : 1.4000 (-0.71%)
Cancer Treatment Revolution Drives $903B Market as New Therapies Gain Momentum BayStreet.ca - Thu Aug 28, 8:31AM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – Researchers at Moffitt Cancer Center have uncovered a promising new therapeutic strategy that could potentially...

ONCY : 0.9931 (-0.53%)
BCT.TO : 13.44 (-5.82%)
MGNX : 1.4000 (-0.71%)
KPTI : 6.95 (-0.71%)
BCTX : 9.54 (-7.47%)
CTOR : 1.1300 (unch)
MacroGenics: Q2 Earnings Snapshot AP - Thu Aug 14, 3:10PM CDT

MacroGenics: Q2 Earnings Snapshot

MGNX : 1.4000 (-0.71%)
MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities GlobeNewswire - Thu Aug 14, 3:01PM CDT

Newly-appointed President and CEO, Eric Risser, outlines strategic priorities for 2025 and 2026 Received $70 million upfront cash payment from Sagard Healthcare Partners under a royalty purchase agreement...

MGNX : 1.4000 (-0.71%)
MacroGenics Appoints Eric Risser as President and Chief Executive Officer GlobeNewswire - Wed Aug 13, 3:01PM CDT

ROCKVILLE, MD, Aug. 13, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company developing innovative antibody-based therapeutics for the treatment of cancer,...

MGNX : 1.4000 (-0.71%)
Investors Turn to Cancer Breakthroughs as Federal Funding Faces Deep Cuts BayStreet.ca - Tue Jul 8, 8:39AM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – With cancer cases rising and treatment costs hitting new highs, the private sector is under growing pressure...

ONCY : 0.9931 (-0.53%)
MGNX : 1.4000 (-0.71%)
AGEN : 3.79 (-7.11%)
TIL : 10.84 (-1.09%)
ONC.TO : 1.42 (+2.16%)
CATX : 2.67 (-1.11%)

Barchart Exclusives

JPMorgan Says This 1 Chip Stock Is a Strong Buy Now... And It’s Not What You Think It Is Barchart - Sat Dec 13, 11:00AM CST
J.P. Morgan upgraded Pepsi, citing expectations for improved performance. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot